Krystal Biotech, Inc. (KRYS) stock analysis

In our weekly check, Krystal Biotech, Inc. is graded A (A to F). Of 21 checks on debt, profit, cash flow and trend: 17 pass, warnings: 4, red flags: 0.

About Krystal Biotech, Inc.

Krystal Biotech, Inc. is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as KRYS.

What our checks show for KRYS

Warning signs

Strengths

Similar companies

PRAX · PTGX · TGTX · SYRE · MDGL · PCVX

Questions

What grade does Krystal Biotech, Inc. (KRYS) have?

In our weekly check, Krystal Biotech, Inc. is graded A (A to F). Of 21 checks on debt, profit, cash flow and trend: 17 pass, warnings: 4, red flags: 0. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of KRYS stock?

This week's biggest flags for Krystal Biotech, Inc.: High P/E, Very volatile, Deep past fall. In total 4 of 21 checks show a warning or a red flag.

What does Krystal Biotech, Inc. do?

Krystal Biotech, Inc. is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as KRYS.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-11-14

Open the full analysis